Share on StockTwits

Arrowhead Research Corp (NASDAQ:ARWR)‘s stock had its “buy” rating reaffirmed by equities research analysts at Deutsche Bank in a research note issued to investors on Wednesday.

Arrowhead Research Corp (NASDAQ:ARWR) traded down 3.85% on Wednesday, hitting $12.50. The stock had a trading volume of 3,880,067 shares. Arrowhead Research Corp has a 1-year low of $3.75 and a 1-year high of $27.63. The stock’s 50-day moving average is $12.3 and its 200-day moving average is $15.03. The company’s market cap is $648.4 million. Arrowhead Research Corp also was the target of some unusual options trading on Tuesday. Traders purchased 12,678 call options on the company. This represents an increase of approximately 379% compared to the average daily volume of 2,648 call options.

Arrowhead Research Corp (NASDAQ:ARWR) last released its earnings data on Tuesday, August 12th. The company reported ($0.22) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.22). On average, analysts predict that Arrowhead Research Corp will post $-0.94 earnings per share for the current fiscal year.

Separately, analysts at Jefferies Group raised their price target on shares of Arrowhead Research Corp from $29.00 to $30.00 in a research note on Friday, June 20th. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a buy rating, Arrowhead Research Corp currently has an average rating of “Buy” and an average target price of $24.29.

Arrowhead Research Corporation (NASDAQ:ARWR) is a biopharmaceutical company developing targeted RNAi therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.